It was noted that the minor allele (T) homozygotes for the TCF7L2 rs12255372 conferred 3.8 fold reduced risk for the development of breast cancers compared to women having major allele (G) homozygosity (OR, 0.264; CI, 0.093–0.750). The gene discussed is TCF7L2; the disease is breast cancer.